Infantile neuronal ceroid lipofuscinosis (INCL) is caused by deficiency of the lysosomal enzyme, palmitoyl protein thioesterase 1 (PPT1). We have investigated the onset and progression of pathological changes in Ppt1 deficient mice (Ppt1 −/− ) and the development of their seizure phenotype. Surprisingly, cortical atrophy and neuron loss occurred only late in disease progression but were preceded by localized astrocytosis within individual thalamic nuclei and the progressive loss of thalamic neurons that relay different sensory modalities to the cortex. This thalamic neuron loss occurred first within the visual system and only subsequently in auditory and somatosensory relay nuclei or the inhibitory reticular thalamic nucleus. The loss of granule neurons and GABAergic interneurons followed in each corresponding cortical region, before the onset of seizure activity. These findings provide novel evidence for successive neuron loss within the thalamus and cortex in Ppt1 −/− mice, revealing the thalamus as an important early focus of INCL pathogenesis.
Introduction
Batten disease, or neuronal ceroid lipofuscinosis (NCL), is the most frequent autosomal-recessive storage disorder of childhood (Cooper, 2003) . At least eight forms of this fatal neurodegenerative disorder exist, each due to mutations in a different gene and characterized by the accumulation of autofluorescent storage material (Cooper, 2003; Mole et al., 2005) . The different forms of NCL are typically classified by age of onset, with infantile NCL (INCL) exhibiting the earliest onset and most rapid course (Haltia et al., 1973a,b; Santavuori et al., 1973) . Affected children develop normally until 12 months, but subsequently undergo complete retinal degeneration and blindness, cognitive and motor deficits, seizures and a flat electroencephalogram by 3 years. These children remain in a vegetative state for several years and with no effective treatment available will invariably die (Santavuori et al., 1973; Mole et al., 2005) . At autopsy, these patients show massive neuronal degeneration that is most pronounced, but not confined, to the cortex (Haltia et al., 1973a,b) .
INCL is caused by mutations in the CLN1 gene encoding palmitoyl protein thioesterase 1 (PPT1), a soluble lysosomal enzyme (Vesa et al., 1995) whose function is to remove long-chain fatty acids from modified cysteine residues (Hofmann et al., 2001; Lu et al., 2002) . However, the precise role of PPT1 in the CNS is uncertain and the mechanisms by which PPT1 deficiency leads to the devastating clinical profile of INCL remain poorly understood. 
